113 related articles for article (PubMed ID: 8057670)
41. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.
Said JW; Sassoon AF; Shintaku IP; Kurtin PJ; Pinkus GS
Am J Pathol; 1991 Feb; 138(2):261-4. PubMed ID: 1899539
[TBL] [Abstract][Full Text] [Related]
42. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
44. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
Miyamura K; Kobayashi T; Sasaki T; Ibuka T; Imai K; Sakai Y; Kawaguchi K; Miyashita T; Iwaya M; Mizutani S
Int J Hematol; 1991 Apr; 54(2):137-40. PubMed ID: 1747446
[TBL] [Abstract][Full Text] [Related]
45. Application of a PCR-mismatch technique to the BCL-2 gene: detection of point mutations in BCL-2 genes of malignancies with A t(14,18).
Tanaka S; Louie D; Kant J; Reed JC
Leukemia; 1992; 6 Suppl 3():15S-19S. PubMed ID: 1602814
[TBL] [Abstract][Full Text] [Related]
46. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
[TBL] [Abstract][Full Text] [Related]
47. The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Hübner K; Fischer R; Georgii A
Virchows Arch; 1995; 426(1):37-41. PubMed ID: 7704322
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S; Bodrug S; Gascoyne R; Berean K; Krajewska M; Reed JC
Am J Pathol; 1994 Sep; 145(3):515-25. PubMed ID: 8080035
[TBL] [Abstract][Full Text] [Related]
49. Normal and neoplastic human plasma cells express bcl-2 antigen.
Hamilton MS; Barker HF; Ball J; Drew M; Abbot SD; Franklin IM
Leukemia; 1991 Sep; 5(9):768-71. PubMed ID: 1943229
[TBL] [Abstract][Full Text] [Related]
50. Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): a molecular and immunohistochemical study.
Lambrechts AC; Looijenga LH; van't Veer MB; van Echten J; Timens W; Oosterhuis JW
Br J Cancer; 1995 Jan; 71(1):73-7. PubMed ID: 7819053
[TBL] [Abstract][Full Text] [Related]
51. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas.
Klefstrom J; Franssila K; Peltomäki P; Kaartinen M; Solin ML; Knuutila S
Leuk Res; 1994 Apr; 18(4):245-50. PubMed ID: 8170168
[TBL] [Abstract][Full Text] [Related]
52. Detection of t(14; 18)(q32;q21) in hyperdiploid cells by fluorescence in situ hybridization in a patient with Hodgkin disease.
Miura I; Tamura A; Taniwaki M; Nakamura S; Nakamine H; Yoshino T; Ichinohasama R; Miura AB
Cancer Genet Cytogenet; 2000 Dec; 123(2):97-101. PubMed ID: 11150598
[TBL] [Abstract][Full Text] [Related]
53. Bcl-2 oncogene protein is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype.
Lones MA; Pinkus GS; Shintaku IP; Said JW
Am J Clin Pathol; 1994 Oct; 102(4):464-7. PubMed ID: 7524301
[TBL] [Abstract][Full Text] [Related]
54. Bcl-x gene expression in Hodgkin's disease.
Schlaifer D; Krajewski S; Rigal-Huguet F; Laurent G; Pris J; Delsol G; Reed JC; Brousset P
Leuk Lymphoma; 1996 Sep; 23(1-2):143-6. PubMed ID: 9021697
[TBL] [Abstract][Full Text] [Related]
55. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F; Tse AG; Cordell JL; Pulford KA; Gatter KC; Mason DY
Am J Pathol; 1990 Aug; 137(2):225-32. PubMed ID: 2201196
[TBL] [Abstract][Full Text] [Related]
56. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas.
Tanaka S; Louie DC; Kant JA; Reed JC
Blood; 1992 Jan; 79(1):229-37. PubMed ID: 1339299
[TBL] [Abstract][Full Text] [Related]
57. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas.
Ngan BY; Nourse J; Cleary ML
Blood; 1989 May; 73(7):1759-62. PubMed ID: 2713505
[TBL] [Abstract][Full Text] [Related]
58. Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma.
Cotter F; Price C; Zucca E; Young BD
Blood; 1990 Jul; 76(1):131-5. PubMed ID: 2194586
[TBL] [Abstract][Full Text] [Related]
59. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma.
Lambrechts AC; Hupkes PE; Dorssers LC; van't Veer MB
Blood; 1993 Oct; 82(8):2510-6. PubMed ID: 8400298
[TBL] [Abstract][Full Text] [Related]
60. Germ line configuration of the BCL-2 major breakpoint region in hyperplastic lymph nodes.
Lubínski J; Ptaszynski K; Tsujimoto Y; Huebner K; Croce C
Anal Quant Cytol Histol; 1991 Dec; 13(6):425-8. PubMed ID: 1807284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
